Zobrazeno 1 - 10
of 124
pro vyhledávání: '"Dean Follmann"'
Autor:
Peter B, Gilbert, Ruben O, Donis, Richard A, Koup, Youyi, Fong, Stanley A, Plotkin, Dean, Follmann
Publikováno v:
New England Journal of Medicine. 387:2203-2206
Autor:
Rebekah A, Blakney, Emily E, Ricotta, Timothy B, Frankland, Stacey, Honda, Adrian, Zelazny, Katrin D, Mayer-Barber, Samantha G, Dean, Dean, Follmann, Kenneth N, Olivier, Yihe G, Daida, D Rebecca, Prevots
Publikováno v:
Emerging Infectious Diseases. 28:1543-1550
To further clarify differences in the risk for nontuberculous mycobacterial pulmonary infection (NTM-PI) among ethnic populations in Hawaii, USA, we conducted a retrospective cohort study among beneficiaries of Kaiser Permanente Hawaii (KPH). We abst
Publikováno v:
Statistics in Medicine. 41:2513-2522
It is challenging to evaluate the genetic impacts on a biologic feature and separate them from environmental impacts. This is usually achieved through twin studies by assessing the collective genetic impact defined by the differential correlation in
Autor:
Peter B, Gilbert, David C, Montefiori, Adrian B, McDermott, Youyi, Fong, David, Benkeser, Weiping, Deng, Honghong, Zhou, Christopher R, Houchens, Karen, Martins, Lakshmi, Jayashankar, Flora, Castellino, Britta, Flach, Bob C, Lin, Sarah, O'Connell, Charlene, McDanal, Amanda, Eaton, Marcella, Sarzotti-Kelsoe, Yiwen, Lu, Chenchen, Yu, Bhavesh, Borate, Lars W P, van der Laan, Nima S, Hejazi, Chuong, Huynh, Jacqueline, Miller, Hana M, El Sahly, Lindsey R, Baden, Mira, Baron, Luis, De La Cruz, Cynthia, Gay, Spyros, Kalams, Colleen F, Kelley, Michele P, Andrasik, James G, Kublin, Lawrence, Corey, Kathleen M, Neuzil, Lindsay N, Carpp, Rolando, Pajon, Dean, Follmann, Ruben O, Donis, Richard A, Koup
Publikováno v:
Science. 375:43-50
Antibody levels predict vaccine efficacy Symptomatic COVID-19 infection can be prevented by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines. A “correlate of protection” is a molecular biomarker to measure how much immunity i
Autor:
Qingbo Liu, Huiyi Miao, Shuai Li, Peng Zhang, Gloria F. Gerber, Dean Follmann, Hongkai Ji, Scott L. Zeger, Daniel S. Chertow, Thomas C. Quinn, Matthew L. Robinson, Thomas S. Kickler, Richard E. Rothman, Katherine Z. J. Fenstermacher, Evan M. Braunstein, Andrea L. Cox, Patrizia Farci, Anthony S. Fauci, Paolo Lusso
Publikováno v:
Proceedings of the National Academy of Sciences. 119
Severe COVID-19 is characterized by a prothrombotic state associated with thrombocytopenia, with microvascular thrombosis being almost invariably present in the lung and other organs at postmortem examination. We evaluated the presence of antibodies
Autor:
Aurelie Gouel-Cheron, Bruce J. Swihart, Sarah Warner, Lauren Mathew, Jeffrey R. Strich, Alex Mancera, Dean Follmann, Sameer S. Kadri
Publikováno v:
Critical care medicine. 50(12)
Bloodstream infections (BSIs) acquired in the ICU represent a detrimental yet potentially preventable condition. We determined the prevalence of BSI acquired in the ICU (ICU-onset BSI), pathogen profile, and associated risk factors.Retrospective coho
Autor:
Dean Follmann, Holly E. Janes, Olive D. Buhule, Honghong Zhou, Bethany Girard, Kristen Marks, Karen Kotloff, Michaël Desjardins, Lawrence Corey, Kathleen M. Neuzil, Jacqueline M. Miller, Hana M. El Sahly, Lindsey R. Baden
Publikováno v:
Annals of internal medicine. 175(9)
Immunoassays for determining past SARS-CoV-2 infection have not been systematically evaluated in vaccinated persons in comparison with unvaccinated persons.To evaluate antinucleocapsid antibody (anti-N Ab) seropositivity in mRNA-1273 (Moderna) vaccin
Autor:
Youyi, Fong, Adrian B, McDermott, David, Benkeser, Sanne, Roels, Daniel J, Stieh, An, Vandebosch, Mathieu, Le Gars, Griet A, Van Roey, Christopher R, Houchens, Karen, Martins, Lakshmi, Jayashankar, Flora, Castellino, Obrimpong, Amoa-Awua, Manjula, Basappa, Britta, Flach, Bob C, Lin, Christopher, Moore, Mursal, Naisan, Muhammed, Naqvi, Sandeep, Narpala, Sarah, O'Connell, Allen, Mueller, Leo, Serebryannyy, Mike, Castro, Jennifer, Wang, Christos J, Petropoulos, Alex, Luedtke, Ollivier, Hyrien, Yiwen, Lu, Chenchen, Yu, Bhavesh, Borate, Lars W P, van der Laan, Nima S, Hejazi, Avi, Kenny, Marco, Carone, Daniel N, Wolfe, Jerald, Sadoff, Glenda E, Gray, Beatriz, Grinsztejn, Paul A, Goepfert, Susan J, Little, Leonardo, Paiva de Sousa, Rebone, Maboa, April K, Randhawa, Michele P, Andrasik, Jenny, Hendriks, Carla, Truyers, Frank, Struyf, Hanneke, Schuitemaker, Macaya, Douoguih, James G, Kublin, Lawrence, Corey, Kathleen M, Neuzil, Lindsay N, Carpp, Dean, Follmann, Peter B, Gilbert, Richard A, Koup, Ruben O, Donis
Publikováno v:
Nature microbiology. 7(12)
Measuring immune correlates of disease acquisition and protection in the context of a clinical trial is a prerequisite for improved vaccine design. We analysed binding and neutralizing antibody measurements 4 weeks post vaccination as correlates of r
Publikováno v:
Critical care medicine. 50(7)
Prior research has hypothesized the Sequential Organ Failure Assessment (SOFA) score to be a poor predictor of mortality in mechanically ventilated patients with COVID-19. Yet, several U.S. states have proposed SOFA-based algorithms for ventilator tr
Autor:
Elizabeth R. Brown, Youyi Fong, Kathleen M. Neuzil, Holly Janes, Shu Han, Peter B. Gilbert, Iksung Cho, Yunda Huang, Michael P. Fay, Lindsay N. Carpp, An Vandebosch, Thomas R. Fleming, Martha Nason, David Benkeser, Marco Carone, Ying Huang, Paula W. Annunziato, Alex Luedtke, Jonathan Hartzel, Ian Hirsch, Deborah Donnell, Michal Juraska, Myron S. Cohen, Honghong Zhou, Devan V. Mehrotra, Ollivier Hyrien, Dean Follmann, Lawrence Corey
Publikováno v:
Annals of Internal Medicine
Safe and effective vaccines are a critical component in the control of COVID-19. A group of industry, government, and academic researchers discuss pragmatic issues in the choice and interpretation of clinical endpoints for evaluating efficacy in COVI